Inato Stock

Inato is a platform designed for clinical trials that can unlock research site potential.

Sign up today and learn more about Inato Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Inato Stock

Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps new therapies arrive to patients faster, and at lower prices

Funding History

November 2017$1.3M
February 2020$14.0M


Co-Founder and CPO

William Pambrun

Chief Strategy Officer

Liz Beatty

Co-Founder and Chief Medical Officer

Jean-David Zeitoun

Co-Founder and Chief Scientific Officer

Philippe Ravaud

Co-Founder and CEO

Kourosh Davarpanah


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: